96 related articles for article (PubMed ID: 36356272)
1. Feasibility and acceptability of telehealth and contactless delivery of human papillomavirus (HPV) self-testing for cervical screening with Māori and Pacific women in a COVID-19 outbreak in Aotearoa New Zealand.
Bartholomew K; Grant J; Maxwell A; Bromhead C; Gillett F; Saraf R; Moodabe K; Sherman SM; McPherson G; Flower D; Kathuria J; Crengle S; Massey R; Scott N; Coote P
N Z Med J; 2022 Nov; 135(1565):83-94. PubMed ID: 36356272
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus (HPV) Self-Sampling among Never-and Under-Screened Indigenous Māori, Pacific and Asian Women in Aotearoa New Zealand: A Feasibility Study.
Bromhead C; Wihongi H; Sherman SM; Crengle S; Grant J; Martin G; Maxwell A; McPherson G; Puloka '; Reid S; Scott N; Bartholomew K
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639352
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus self-testing among unscreened and under-screened Māori, Pasifika and Asian women in Aotearoa New Zealand: A preference survey among responders and interviews with clinical-trial nonresponders.
Sherman SM; Brewer N; Bartholomew K; Bromhead C; Crengle S; Cunningham C; Douwes J; Foliaki S; Grant J; Maxwell A; McPherson G; Scott N; Wihongi H; Potter JD
Health Expect; 2022 Dec; 25(6):2914-2923. PubMed ID: 36161964
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
[TBL] [Abstract][Full Text] [Related]
5. He Tapu Te Whare Tangata (sacred house of humanity): Under-screened Māori women talk about HPV self-testing cervical screening clinical pathways.
Adcock A; Stevenson K; Cram F; MacDonald EJ; Geller S; Hermens J; Lawton B
Int J Gynaecol Obstet; 2021 Nov; 155(2):275-281. PubMed ID: 34382217
[TBL] [Abstract][Full Text] [Related]
6. Te Ara Waiora-Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial.
Gibson-Helm M; Slater T; MacDonald EJ; Stevenson K; Adcock A; Geller S; Parag V; Lambert C; Bennett M; Hibma M; Sykes P; Saville M; Hawkes D; Stanton JA; Clueard MA; Jelley G; Lawton B
PLoS One; 2023; 18(3):e0280643. PubMed ID: 36952546
[TBL] [Abstract][Full Text] [Related]
7. Preliminary assessment of using mobile point-of-care human papillomavirus (HPV) testing with the option of immediate colposcopy in a rural area in a high-income country: a case study.
Paterson H; Macfarlane E; Slater T; Stanton JL; MacDonald EJ; Gibson M; Lawton B
N Z Med J; 2024 Jun; 137(1596):43-51. PubMed ID: 38843549
[TBL] [Abstract][Full Text] [Related]
8. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
Wong EL; Cheung AW; Wong AY; Chan PK
Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
[No Abstract] [Full Text] [Related]
9. National experience in the first two years of primary human papillomavirus (HPV) cervical screening in an HPV vaccinated population in Australia: observational study.
Smith MA; Sherrah M; Sultana F; Castle PE; Arbyn M; Gertig D; Caruana M; Wrede CD; Saville M; Canfell K
BMJ; 2022 Mar; 376():e068582. PubMed ID: 35354610
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Acceptability and Uptake of HPV Self-Sampling Amongst Women Under- or Never-Screened for Cervical Cancer in Toronto (Ontario, Canada): An Intervention Study Protocol.
Lofters A; Devotta K; Prakash V; Vahabi M
Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501703
[TBL] [Abstract][Full Text] [Related]
11. Coverage rate of cervical cytology and HPV DNA test for cervix cancer screening: Reappraisal on impact of COVID-19 outbreak.
Sookaromdee P; Wiwanitkit V
J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S1020-S1021. PubMed ID: 38384106
[No Abstract] [Full Text] [Related]
12. Acceptability of self-taken vaginal HPV sample for cervical screening among an under-screened Indigenous population.
Adcock A; Cram F; Lawton B; Geller S; Hibma M; Sykes P; MacDonald EJ; Dallas-Katoa W; Rendle B; Cornell T; Mataki T; Rangiwhetu T; Gifkins N; Hart S
Aust N Z J Obstet Gynaecol; 2019 Apr; 59(2):301-307. PubMed ID: 30614524
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of p16
Song F; Belinson JL; Yan P; Huang X; Wang C; Du H; Qu X; Wu R
Gynecol Oncol; 2021 Aug; 162(2):322-330. PubMed ID: 34059349
[TBL] [Abstract][Full Text] [Related]
14. Acceptability of human papillomavirus self-sampling for cervical-cancer screening in under-screened Māori and Pasifika women: a pilot study.
Brewer N; Foliaki S; Bromhead C; Viliamu-Amusia I; Pelefoti-Gibson L; Jones T; Pearce N; Potter JD; Douwes J
N Z Med J; 2019 Jun; 132(1497):21-31. PubMed ID: 31220062
[TBL] [Abstract][Full Text] [Related]
15. Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.
Cicconi P; Wells C; McCarthy B; Wareing S; Andersson MI; Fox J; Lwanga J; Pal N; Burns F; Woodward C; Malek R; Sabin CA; Dorrell L
HIV Med; 2022 Apr; 23(4):390-396. PubMed ID: 35243750
[TBL] [Abstract][Full Text] [Related]
16. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of human papillomavirus (HPV) self-sampling among never- and under-screened Indigenous and other minority women: a randomised three-arm community trial in Aotearoa New Zealand.
Brewer N; Bartholomew K; Grant J; Maxwell A; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Foliaki S; Cunningham C; Douwes J; Potter JD
Lancet Reg Health West Pac; 2021 Nov; 16():100265. PubMed ID: 34590066
[TBL] [Abstract][Full Text] [Related]
18. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Different HPV-based Strategies and Cytology in Routine Cervical Cancer Screening Programme in China: A Population-based Study.
Wang S; Li L; Yang J; Han N; Bao H; Wang HJ
Cancer Prev Res (Phila); 2022 Jan; 15(1):45-54. PubMed ID: 34556493
[TBL] [Abstract][Full Text] [Related]
20. The first-round results of a population-based cohort study of HPV testing in Japanese cervical cancer screening: baseline characteristics, screening results, and referral rate.
Kono K; Morisada T; Saika K; Aoki ES; Miyagi E; Ito K; Takahashi H; Nakayama T; Saito H; Aoki D
J Gynecol Oncol; 2021 May; 32(3):e29. PubMed ID: 33559411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
